Atlas Capital Advisors’s Dentsply Sirona XRAY Stock Holding History
Bought
Maintained
Sold
Other funds holding XRAY
GIM
CIP
Atlas Capital Advisors's XRAY Position: Q1 2022 in Review
Atlas Capital Advisors sold out of Dentsply Sirona (XRAY) in Q1 2022, closing a stake of 150 shares — an estimated $8.37K sold.
Atlas Capital Advisors first reported a position in XRAY in Q4 2019 and held it in 5 quarters. The position peaked at $22.1K in Q2 2021. 536 funds tracked by Wall St. Rank hold XRAY as of Q1 2022.
- Atlas Capital Advisors reported no remaining Dentsply Sirona position as of Q1 2022 after selling out during the quarter.
- Atlas Capital Advisors sold 150 Dentsply Sirona shares in Q1 2022, an estimated $8.37K.
- Atlas Capital Advisors first reported a position in Dentsply Sirona in Q4 2019 and held it in 5 quarters.
- Atlas Capital Advisors's Dentsply Sirona position peaked at $22.1K in Q2 2021.
- 536 funds tracked by Wall St. Rank held Dentsply Sirona as of Q1 2022.
Based on Atlas Capital Advisors's 13F filing for Q1 2022, filed 11 May 2022.